Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

GU Jing-jing, Tian Gui-zhen. Clinical efficacy on chronic hepatitis B treated by lamivudine combination with oxymatrine[J]. Journal of Pharmaceutical Practice and Service, 2003, (1): 3-4.
Citation: GU Jing-jing, Tian Gui-zhen. Clinical efficacy on chronic hepatitis B treated by lamivudine combination with oxymatrine[J]. Journal of Pharmaceutical Practice and Service, 2003, (1): 3-4.

Clinical efficacy on chronic hepatitis B treated by lamivudine combination with oxymatrine

  • Received Date: 2002-04-12
  • OBJECTIVE To study the efficacy and safety of lamivudine combination with oxymatrine in treating chronic hepatitis B.METHODS 67 patients were randomly divided into 2 groups.36 patients as a treatment group received 100mg·d-1,po,lamivudine combination with 600mg·d-1,im oxymatrine for 3 months.31 patients as a control group was treated only with routine therapy.RESULTS After completion of therapy,the change of liver function and mark of HBVM were observed.In the two groups,the recovery rate of ALT was 90.2% and 75.3%,the negative rate of HBeAg was 33.4% and 16.1%.The efficacy of the treatment group was higher than that of control group.(P<0.05).Side effects had not been found.CONCLUSION lamivudine combination with oxymatrine can improve the liver function and inhibit HBV.
  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-04012345Highcharts.com
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 89.4 %FULLTEXT: 89.4 %META: 8.4 %META: 8.4 %PDF: 2.2 %PDF: 2.2 %FULLTEXTMETAPDFHighcharts.com
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 12.6 %其他: 12.6 %China: 0.5 %China: 0.5 %Korea Republic of: 0.5 %Korea Republic of: 0.5 %United States: 0.5 %United States: 0.5 %[]: 0.3 %[]: 0.3 %上海: 0.8 %上海: 0.8 %北京: 11.8 %北京: 11.8 %南京: 0.3 %南京: 0.3 %杭州: 0.3 %杭州: 0.3 %温州: 0.3 %温州: 0.3 %湛江: 0.5 %湛江: 0.5 %芒廷维尤: 18.7 %芒廷维尤: 18.7 %西宁: 52.8 %西宁: 52.8 %马尼拉: 0.3 %马尼拉: 0.3 %其他ChinaKorea Republic ofUnited States[]上海北京南京杭州温州湛江芒廷维尤西宁马尼拉Highcharts.com
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(2446) PDF downloads(943) Cited by()

Related
Proportional views

Clinical efficacy on chronic hepatitis B treated by lamivudine combination with oxymatrine

Abstract: OBJECTIVE To study the efficacy and safety of lamivudine combination with oxymatrine in treating chronic hepatitis B.METHODS 67 patients were randomly divided into 2 groups.36 patients as a treatment group received 100mg·d-1,po,lamivudine combination with 600mg·d-1,im oxymatrine for 3 months.31 patients as a control group was treated only with routine therapy.RESULTS After completion of therapy,the change of liver function and mark of HBVM were observed.In the two groups,the recovery rate of ALT was 90.2% and 75.3%,the negative rate of HBeAg was 33.4% and 16.1%.The efficacy of the treatment group was higher than that of control group.(P<0.05).Side effects had not been found.CONCLUSION lamivudine combination with oxymatrine can improve the liver function and inhibit HBV.

GU Jing-jing, Tian Gui-zhen. Clinical efficacy on chronic hepatitis B treated by lamivudine combination with oxymatrine[J]. Journal of Pharmaceutical Practice and Service, 2003, (1): 3-4.
Citation: GU Jing-jing, Tian Gui-zhen. Clinical efficacy on chronic hepatitis B treated by lamivudine combination with oxymatrine[J]. Journal of Pharmaceutical Practice and Service, 2003, (1): 3-4.

Catalog

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return